Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bacterial mutation test on plafibride

M Richold, E Jones

    Arzneimittel-Forschung
    |January 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Plafibride (ITA 104) was evaluated for its potential to cause genetic mutations using the Ames test. This study found no evidence of mutagenic activity for plafibride in bacterial strains, with or without liver microsome activation.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Does the use of health technology assessment have an impact on the utilisation of health care resources? Evidence from two European countries.

    The European journal of health economics : HEPAC : health economics in prevention and care·2020
    Same author

    Hypertension in pregnancy: A future risk for chronic kidney disease in South Africa.

    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2019
    Same author

    The impact of an epilepsy nurse competency framework on the costs of supporting adults with epilepsy and intellectual disability: findings from the EpAID study.

    Journal of intellectual disability research : JIDR·2019
    Same author

    A crosslinked collagen membrane versus a non-crosslinked bilayer collagen membrane for supporting osteogenic functions of human bone marrow-multipotent stromal cells.

    European cells & materials·2019
    Same author

    Use of bioengineered human commensal gut bacteria-derived microvesicles for mucosal plague vaccine delivery and immunization.

    Clinical and experimental immunology·2019
    Same author

    Quality of care assessment for people with multimorbidity.

    Journal of internal medicine·2019

    Area of Science:

    • Pharmacology
    • Toxicology
    • Genetics

    Background:

    • Plafibride (ITA 104) is a compound requiring assessment for potential genotoxicity.
    • Mutagenicity testing is crucial for evaluating drug safety and regulatory approval.

    Purpose of the Study:

    • To determine the mutagenic potential of plafibride (ITA 104).
    • To assess plafibride's mutagenicity using the Ames Salmonella/mammalian microsome test.

    Main Methods:

    • Utilized Salmonella typhimurium strains TA 1535, TA 1537, TA 1538, TA 98, and TA 100.
    • Tested for mutagenicity in both the presence and absence of a liver microsomal supplement.
    • Employed strains sensitive to base pair substitution and frame-shift mutagens.

    Main Results:

    Related Experiment Videos

    • No mutagenic activity was detected for plafibride across all tested Salmonella strains.
    • The results remained consistent regardless of the addition of a liver microsomal supplement.

    Conclusions:

    • Plafibride (ITA 104) does not exhibit mutagenic properties in the Ames test.
    • The compound is considered non-mutagenic under the conditions tested, suggesting a favorable genotoxic profile.